Pregnant individuals in Ontario have only been designated a priority population for COVID-19 vaccination since late April 2021. Researchers are now able to provide long-sought insights into vaccine uptake in this population. In a study supported by the VSRG and the CITF, Dr. Deshayne Fell and her team at the Better Outcomes Registry & [...]
The race to vaccinate the world became more urgent with the emergence of variants of concern (VOCs). In a recent pre-print, not yet peer-reviewed, researchers from the Canadian Immunization Research Network (CIRN), including CITF-funded researchers Dr. Deshayne Fell, Dr. Jeff Kwong and Dr. Kumanan Wilson, estimated the effectiveness of vaccines given between December 2020 [...]
mRNA COVID-19 vaccines are shown to be highly effective after two doses against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes
Researchers from the Canadian Immunization Research Network (CIRN) assessed the effectiveness of mRNA vaccines against symptomatic COVID-19 infection and severe outcomes and showed promising results. Researchers suggest that while one dose of the mRNA vaccine provides some protection that improves over time, two doses appear to be highly effective against severe outcomes. Their study [...]
Canadian study investigates immune response and vaccine hesitancy among Canada’s South Asian communities
The Government of Canada, through its COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group is supporting a new pan-Canadian study that will investigate the immune response to the COVID-19 vaccine within the South Asian community.
The Government of Canada, through the COVID-19 Immunity Task Force (CITF) and the Vaccine Surveillance Reference Group (VSRG), is supporting a new nation-wide study that will look at the effects of ‘mixing-and-matching’ approved COVID-19 vaccines in adults. Approximately $4.8 million is being provided for this study, which will assess the safety and effectiveness of using two different COVID-19 vaccines for the first and second dose. The project will also study the effects of increasing the interval between doses.
The Government of Canada, through its COVID-19 Immunity Task Force (CITF) and Vaccine Surveillance Reference Group (VSRG), is investing approximately $1.3 million for two Canadian research teams to further evaluate vaccine safety and effectiveness in pregnant people.
A consortium of Canadian organizations, including the Public Health Agency of Canada (PHAC), the Canadian Research Immunization Network (CIRN), the National Advisory Committee on Immunization (NACI) and the CITF, are collaborating through the Vaccine Surveillance Reference group (VSRG) to identify new studies to support comprehensive vaccine effectiveness and safety monitoring efforts across Canada.
Most Montreal parents willing to vaccinate their children, but vaccine hesitancy more prominent among visible minorities
Health Canada approved the use of Pfizer-BioNTech’s COVID-19 vaccine on children 12 and older on May 5, 2021. As part of her CITF-funded research, Dr. Kate Zinszer, from Université de Montréal, and her colleagues examined willingness to vaccinate children according to level of education, neighbourhood, and visible minority status within a cohort of parents [...]